Several studies have reported how the combination of PTEN inactivation with either KRAS p.G12D or HRAS p.G12V causes cyclin D1-dependent cell cycle dysregulation, enhanced MAPK activation and an immunosuppressive tumor microenvironment, promoting metastatic spread and progression of follicular carcinoma (136, 137, 138). Here, HRAS is linked to neoplasm.